C-reactive protein to albumin ratio may predict in-hospital mortality in non-ST elevation myocardial infarction.
Tuğba S Menekşeİlker KaçerMuhammet HacımustafaoğluMurat GulEsen Sayın GülensoyPublished in: Biomarkers in medicine (2024)
Objective: The authors investigated the value of novel inflammatory markers, systemic immune-inflammation index and C-reactive protein to albumin ratio (CAR), to predict in-hospital mortality in patients with non-ST elevation myocardial infarction (NSTEMI). Materials & methods: A total of 308 patients who underwent percutaneous coronary intervention because of NSTEMI were retrospectively included in the study. Killip classification, Thrombolysis in Myocardial Infarction score, SYNTAX score, and CAR and systemic immune-inflammation index values were calculated. Results: CAR (cutoff: 0.0864; sensitivity: 94.1%; specificity: 40.5%; p = 0.008) and Killip classification (cutoff: 2.5; sensitivity: 64.7%; specificity: 8.9%; p = 0.001) were found to be significantly higher in determining in-hospital mortality. Conclusion: This study revealed that CAR is an inexpensive and significant factor in predicting in-hospital mortality in patients undergoing percutaneous coronary intervention for NSTEMI.
Keyphrases
- st elevation myocardial infarction
- percutaneous coronary intervention
- st segment elevation myocardial infarction
- acute myocardial infarction
- acute coronary syndrome
- coronary artery disease
- antiplatelet therapy
- coronary artery bypass grafting
- oxidative stress
- patients undergoing
- end stage renal disease
- machine learning
- deep learning
- atrial fibrillation
- newly diagnosed
- chronic kidney disease
- coronary artery bypass
- ejection fraction
- peritoneal dialysis
- left ventricular
- single cell
- patient reported